North Star Investment Management Corp. cut its position in shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 0.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 37,857 shares of the pharmacy operator’s stock after selling 250 shares during the period. North Star Investment Management Corp.’s holdings in Walgreens Boots Alliance were worth $3,052,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in WBA. Thomaspartners Inc. increased its position in shares of Walgreens Boots Alliance by 0.4% in the second quarter. Thomaspartners Inc. now owns 4,337 shares of the pharmacy operator’s stock worth $361,000 after buying an additional 18 shares in the last quarter. First Citizens Bank & Trust Co. increased its position in shares of Walgreens Boots Alliance by 0.9% in the second quarter. First Citizens Bank & Trust Co. now owns 2,470 shares of the pharmacy operator’s stock worth $206,000 after buying an additional 21 shares in the last quarter. Blue Chip Partners Inc. increased its position in shares of Walgreens Boots Alliance by 0.4% in the second quarter. Blue Chip Partners Inc. now owns 6,633 shares of the pharmacy operator’s stock worth $552,000 after buying an additional 24 shares in the last quarter. Cobiz Investment Management LLC increased its position in shares of Walgreens Boots Alliance by 0.3% in the third quarter. Cobiz Investment Management LLC now owns 7,423 shares of the pharmacy operator’s stock worth $598,000 after buying an additional 25 shares in the last quarter. Finally, Atlanta Capital Group increased its position in shares of Walgreens Boots Alliance by 1.1% in the second quarter. Atlanta Capital Group now owns 4,088 shares of the pharmacy operator’s stock worth $340,000 after buying an additional 45 shares in the last quarter. Institutional investors own 58.93% of the company’s stock.

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded up 1.09% during mid-day trading on Monday, hitting $85.35. 3,956,847 shares of the company’s stock were exchanged. Walgreens Boots Alliance Inc. has a 52 week low of $71.50 and a 52 week high of $87.05. The firm has a 50 day moving average of $81.44 and a 200 day moving average of $81.10. The stock has a market capitalization of $92.46 billion, a P/E ratio of 22.34 and a beta of 1.19.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, October 20th. The pharmacy operator reported $1.07 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.08. The firm earned $28.60 billion during the quarter, compared to analysts’ expectations of $29.06 billion. Walgreens Boots Alliance had a net margin of 3.56% and a return on equity of 16.33%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.88 EPS. Equities analysts forecast that Walgreens Boots Alliance Inc. will post $5.01 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, December 12th. Investors of record on Thursday, November 17th will be paid a dividend of $0.375 per share. This represents a $1.50 annualized dividend and a yield of 1.78%. The ex-dividend date is Tuesday, November 15th. Walgreens Boots Alliance’s payout ratio is currently 39.27%.

WARNING: This report was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was illegally stolen and republished in violation of U.S. & international trademark & copyright legislation. The original version of this report can be read at https://www.thecerbatgem.com/2016/11/28/walgreens-boots-alliance-inc-wba-shares-sold-by-north-star-investment-management-corp.html.

A number of brokerages have recently commented on WBA. Jefferies Group set a $95.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, November 8th. Credit Suisse Group AG reaffirmed a “buy” rating and set a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, October 3rd. Deutsche Bank AG reaffirmed a “buy” rating and set a $88.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, November 10th. Leerink Swann set a $90.00 price target on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Tuesday, November 8th. Finally, Zacks Investment Research downgraded shares of Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research note on Thursday, October 6th. One analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $90.30.

In other news, Director William C. Foote sold 2,067 shares of the stock in a transaction on Wednesday, November 2nd. The shares were sold at an average price of $81.30, for a total value of $168,047.10. Following the completion of the transaction, the director now owns 24,623 shares in the company, valued at approximately $2,001,849.90. The sale was disclosed in a filing with the SEC, which is available at this link. Also, EVP Kathleen Wilson-Thompson sold 23,996 shares of the stock in a transaction on Thursday, September 8th. The shares were sold at an average price of $85.00, for a total transaction of $2,039,660.00. The disclosure for this sale can be found here. Corporate insiders own 21.10% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.